Jubilant Radiopharma Receives Approval from Health Canada for Drax Exametazime®
January 27, 2020 16:05 ET
|
Jubilant Pharma
YARDLEY, Pa., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Jubilant Radiopharma, the Radiopharmaceutical Division of Jubilant Pharma Ltd, announced today that the company received approval from Health Canada...
Jubilant Receives Favorable Ruling from the U.S. Courts for RUBY-FILL®
December 11, 2019 16:45 ET
|
Jubilant Pharma
YARDLEY, Pa., Dec. 11, 2019 (GLOBE NEWSWIRE) -- On December 2, 2019, Jubilant DraxImage Inc. and certain of its affiliates (“Jubilant”) received notice of the favorable decision of the U.S....